| Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion NH McClenaghan, CR Barnett, E Ah-Sing, YHA Abdel-Wahab, ... Diabetes 45 (8), 1132-1140, 1996 | 391 | 1996 |
| Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes JR Lindsay, NA Duffy, AM McKillop, J Ardill, FPM O'Harte, PR Flatt, ... Diabetic Medicine 22 (5), 654-657, 2005 | 248 | 2005 |
| Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3) GIP administration improves glucose tolerance and ameliorates insulin resistance and … VA Gault, N Irwin, BD Green, JT McCluskey, B Greer, CJ Bailey, P Harriott, ... Diabetes 54 (8), 2436-2446, 2005 | 190 | 2005 |
| Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1 BD Green, N Irwin, NA Duffy, VA Gault, FPM O'harte, PR Flatt European journal of pharmacology 547 (1-3), 192-199, 2006 | 169 | 2006 |
| Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese … VA Gault, FPM O'harte, P Harriott, MH Mooney, BD Green, PR Flatt Diabetologia 46, 222-230, 2003 | 145 | 2003 |
| Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents BD Green, VA Gault, FPM O'harte, PR Flatt Current pharmaceutical design 10 (29), 3651-3662, 2004 | 137 | 2004 |
| Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic B-cell line. NH McClenaghan, CR Barnett, FP O'Harte, PR Flatt The Journal of endocrinology 151 (3), 349-357, 1996 | 135 | 1996 |
| Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans SJ Hunter, AC Boyd, FPM O’Harte, AM McKillop, MI Wiggam, MH Mooney, ... Diabetes 52 (2), 492-498, 2003 | 130 | 2003 |
| Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide VA Gault, FPM O'Harte, P Harriott, PR Flatt Biochemical and biophysical research communications 290 (5), 1420-1426, 2002 | 129 | 2002 |
| Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes VA Gault, PR Flatt, FPM O’Harte Biochemical and biophysical research communications 308 (2), 207-213, 2003 | 122 | 2003 |
| Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda JM Conlon, F O'Harte, DD Smith, MC Tonon, H Vaudry Biochemical and biophysical research communications 188 (2), 578-583, 1992 | 115 | 1992 |
| Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential? VA Gault, FPM O’Harte, PR Flatt Neuropeptides 37 (5), 253-263, 2003 | 114 | 2003 |
| Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP (3-42), is a GIP receptor antagonist in vivo VA Gault, JC Parker, P Harriott, PR Flatt, FPM O'Harte Journal of endocrinology 175 (2), 525-534, 2002 | 113 | 2002 |
| Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic … N Irwin, PL McClean, FPM O’harte, VA Gault, P Harriott, PR Flatt Diabetologia 50, 1532-1540, 2007 | 106 | 2007 |
| Glycation of insulin in the islets of Langerhans of normal and diabetic animals YHA Abdel-Wahab, FP O'Harte, H Ratcliff, NH McClenaghan, CR Barnett, ... Diabetes 45 (11), 1489-1496, 1996 | 102 | 1996 |
| Methylmalonyl-CoA mutase (EC 5.4. 99.2) and methionine synthetase (EC 2.1. 1.13) in the tissues of cobalt–vitamin B12 deficient sheep DG Kennedy, A Cannavan, A Molloy, F O'harte, SM Taylor, S Kennedy, ... British Journal of Nutrition 64 (3), 721-732, 1990 | 98 | 1990 |
| Atlantic salmon (Salmo salar) co-product-derived protein hydrolysates: A source of antidiabetic peptides PA Harnedy, V Parthsarathy, CM McLaughlin, MB O'Keeffe, PJ Allsopp, ... Food Research International 106, 598-606, 2018 | 94 | 2018 |
| Identification of the site of glycation of human insulin FPM O'Harte, P Højrup, CR Barnett, PR Flatt Peptides 17 (8), 1323-1330, 1996 | 92 | 1996 |
| Localization of neurokinin B in the central nervous system of the rat I Merchenthaler, JL Maderdrut, F O'Harte, JM Conlon Peptides 13 (4), 815-829, 1992 | 79 | 1992 |
| NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity. FP O'Harte, MH Mooney, PR Flatt Diabetes 48 (4), 758-765, 1999 | 78 | 1999 |
Peter R FlattProfessor, University of Ulster在 ulster.ac.uk 的电子邮件经过验证
